Mankind Pharma Limited (NSE:MANKIND)

India · Delayed Price · Currency is INR

2,125.00

+20.60 (0.98%)

Apr 17, 2026, 3:29 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019
Pharmaceuticals	122.07B	102.60B	87.49B	77.82B	62.14B
Pharmaceuticals Growth	18.98%	17.27%	12.44%	25.22%	5.83%
Total	122.07B	102.60B	87.49B	77.82B	62.14B
Total Growth	18.98%	17.27%	12.44%	25.22%	5.83%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019
India	106.75B	94.47B	84.47B	75.95B	60.29B
India Growth	13.00%	11.84%	11.22%	25.98%	4.14%
Outside India	15.32B	8.13B	2.96B	1.87B	1.86B
Outside India Growth	88.39%	174.97%	58.36%	0.49%	143.31%
Total	122.07B	102.60B	87.43B	77.82B	62.14B
Total Growth	18.98%	17.36%	12.35%	25.22%	5.83%

Source: S&P Global Market Intelligence.